The Flow Cytometry Core Facility (FCCF) at H. Lee Moffitt Cancer Center &Research Institute was established in 1990 to provide a centralized flow cytometry service for Cancer Center members and University of South Florida faculty with cancer related research interests. Flow cytometry is an indispensable analytical tool for cell biology, immunology, and translational research efforts at the Cancer Center. This technology provides a means for rapidly and accurately analyzing multiple characteristics of biological particles, as well as the ability to rapidly isolate and purify cell populations of interest for the purpose of assessing immunological function and molecular distinctions, cell culture cloning, and animal transplantation studies. The FCCF is staffed with highly trained instrument specialists with a combined 21 years of researchbased flow cytometry experience. The facility houses five benchtop analyzers, two high-speed cell sorters, a bead array analyzer, an automated bead sorter, and a fluorescent microscope. The FCCF provides several services including multi-parameter analysis, cell sorting, data analysis and graphics programs, instrument training, project consultation, flow cytometry courses, and application workshops. It also houses a current literature base including cytometry journals and textbooks;vendor information on instrumentation, reagents, and services;and handbooks on flow cytometry-based methodology, procedures and techniques. Overall usage in the FCCF has increased more than 180% since the 2000 CCSG submission as a result of investigator recruitment, increased instrument capacity, and the initiative to train users to operate the benchtop cytometers, which allows them unlimited independent access. Over 39 peer-reviewed investigators across all research programs routinely access the FCCF, totaling 88% usage of acquisition service, 85% usage for cell sorting, and 80% of service training. Usage is expected to grow with investigator recruitment over the next few years. The Core Facility provides critical support for the scientific programs at the Cancer Center by giving investigators access to state-of-the-art instrumentation, cutting-edge cytometry applications, and exceptionally trained staff committed to contributing to outstanding scientific research efforts to understand and control cancer biology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-12
Application #
8055322
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-02-01
Budget End
2011-01-31
Support Year
12
Fiscal Year
2010
Total Cost
$151,067
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Kahen, Elliot John; Brohl, Andrew; Yu, Diana et al. (2018) Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors. Oncotarget 9:22571-22585
Hoffman, Melissa A; Fang, Bin; Haura, Eric B et al. (2018) Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer. J Proteome Res 17:63-75
Puri, Sonam; Hyland, Kelly A; Weiss, Kristine Crowe et al. (2018) Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors. Support Care Cancer 26:2911-2918
Gonzalez, Brian D; Small, Brent J; Cases, Mallory G et al. (2018) Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia. Cancer 124:499-506
Eroglu, Zeynep; Zaretsky, Jesse M; Hu-Lieskovan, Siwen et al. (2018) High response rate to PD-1 blockade in desmoplastic melanomas. Nature 553:347-350
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Phadke, Manali; Remsing Rix, Lily L; Smalley, Inna et al. (2018) Dabrafenib inhibits the growth of BRAF-WT cancers through CDK16 and NEK9 inhibition. Mol Oncol 12:74-88
Kasting, Monica L; Christy, Shannon M; Sutton, Steven K et al. (2018) Florida physicians' reported use of AFIX-based strategies for human papillomavirus vaccination. Prev Med 116:143-149
Jiang, Kun; Neill, Kevin; Cowden, Daniel et al. (2018) Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus. Appl Immunohistochem Mol Morphol 26:552-556
Park, Jae H; Rivière, Isabelle; Gonen, Mithat et al. (2018) Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia. N Engl J Med 378:449-459

Showing the most recent 10 out of 1254 publications